Hims & Hers plummets 16% after first-quarter loss, weak earnings guidance
RSS SUMMARY · AGGREGATED FROM CNBC
Hims & Hers reached a deal with Novo Nordisk in March to sell its GLP-1 weight loss drug Wegovy on its platform.
Hims & Hers reached a deal with Novo Nordisk in March to sell its GLP-1 weight loss drug Wegovy on its platform.
Hims & Hers reached a deal with Novo Nordisk in March to sell its GLP-1 weight loss drug Wegovy on its platform.
Continue Reading
The full story continues on CNBC.
Story Sentry shows a short summary aggregated via RSS. The complete article — original photography, charts, and reporting — lives with the publisher.
The Source
CNBC
Health
Novo Nordisk says high-dose Wegovy helped some patients lose nearly 28% of their weight
CNBC·1h ago·3 min read
Business
It’s not just Iran and oil raising inflation. Prices also are reaccelerating in these other areas
CNBC·47m ago·3 min read
US
Analysis: Iran war hangs over Trump’s China trip — and his presidency
CNBC·2h ago·3 min read
Business
Consumer prices rose 3.8% annually in April, the highest since May 2023
CNBC·2h ago·3 min read
Related
On this beat
US
He hunted for his daughter’s killer for 40 years. Then he got a phone call
THE GUARDIAN·1h ago·3 min read
US
Alabama can use electoral map that favors Republicans, supreme court rules
THE GUARDIAN·16h ago·3 min read
US
Video shows clashes erupt outside synagogue as anti-Israel mob wreaks havoc at real estate expo
FOX NEWS·49m ago·3 min read
US
Dali ship operator, foreign employee charged in Francis Scott Key Bridge collapse, unsealed indictment shows
FOX NEWS·40m ago·3 min read